Threats to the NCI COE agenda impede our ability to meet the needs of our cancer center catchment area communities

Community Outreach and Engagement (COE), now augmented with the Plan to Enhance Diversity (PED), is critical and central to the impact of NCI-designated cancer centers, and both are set forth as required components for the NCI Cancer Center Support Grant (CCSG).

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

Byline

Kim F. Rhoads, MD, MS, MPH

Associate professor of epidemiology & biostatistics, Associate director for community engagement, Helen Diller Family Comprehensive Cancer Center, UCSF School of Medicine

Folakemi T. Odedina, PhD

Professor, Division of Hematology/Oncology, Enterprise deputy director, Community Outreach & Engagement, Mayo Clinic Comprehensive Cancer Center

Monica L. Baskin, PhD

Professor, Division of Hematology/Oncology, The University of Pittsburgh School of Medicine; Associate director, Community Outreach and Engagement, UPMC Hillman Cancer Center

Vanessa B. Sheppard, PhD

Professor, Theresa A. Thomas Memorial Chair in Cancer Prevention and Control, Founding interim dean, School of Population Health, Associate director, Community Outreach Engagement and Health Disparities Research, Massey Comprehensive Cancer Center, Virginia Commonwealth University

Hayley S. Thompson, PhD

Professor, Department of Oncology, Wayne State University School of Medicine; Associate center director, Community Outreach & Engagement,
Karmanos Cancer Institute

Kimlin Tam Ashing, PhD

Professor, Beckman Research Institute, Associate cancer center director, Community Outreach and Engagement, Founding director, Center of Community Engagement for Research and Education, Deputy director, Division of Health Equities, City of Hope Comprehensive Cancer Center

Charnita Zeigler-Johnson, PhD, MPH

Associate professor of cancer prevention and control, Associate director, Community Outreach and Engagement, Fox Chase Cancer Center, Temple University Health System

DOWNLOAD THE PDF

Table of Contents

YOU MAY BE INTERESTED IN

Guest Editorial

Rathmell: We must put the individual at the center of our approach to ending cancer

When I started this column, I was wanting to retain the sense of connection that I had to the greater cancer community as I stepped away into a period of disconnection.

April 04, 2025

Vol.51 No.13

By W. Kimryn Rathmell

In the Archives

In an oral history now taken down by FDA, Andrew von Eschenbach recounts his stint as the head of both FDA and NCI—simultaneously

Credit: NCI/Linda BartlettIn an oral history conducted by FDA in September 2013, Andrew C. von Eschenbach recounted his eight-month stint in a dual role as both FDA acting commissioner and NCI director.

MD Anderson breaks ground on new Houston-area cancer center

The University of Texas MD Anderson Cancer Center on March 31 broke ground on a new 470,000-square-foot facility in Sugar Land, bringing a range of cancer services closer to those living in Southwest Houston and the surrounding areas.

April 04, 2025

Vol.51 No.13

Clinical Roundup

Fatty acids promote immune suppression and therapy resistance in triple negative breast cancer, Baylor Medicine study finds

A study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer to develop resistance to therapy. Researchers at Baylor College of Medicine showed that lipid accumulation in tumor cells and nearby immune cells promotes immune suppression, but disrupting lipid formulation reverses treatment resistance and the immunosuppressive microenvironment.

April 04, 2025

Vol.51 No.13

Conversation with The Cancer Letter

Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State

The University of Rochester Wilmot Cancer Institute last week was named the 73rd NCI-designated cancer center. Now, New York State has eight NCI-designated cancer centers. Only California has more—ten.

Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology

The U.S. Department of Health and Human Services announced that it is making sweeping revisions by cutting personnel, centralizing functions, and consolidating divisions.

March 28, 2025

Vol.51 No.12

By Claire Marie Porter and Jacquelyn Cobb

Threats to the NCI COE agenda impede our ability to meet the needs of our cancer center catchment area communities

YOU MAY BE INTERESTED IN

Rathmell: We must put the individual at the center of our approach to ending cancer

In an oral history now taken down by FDA, Andrew von Eschenbach recounts his stint as the head of both FDA and NCI—simultaneously

MD Anderson breaks ground on new Houston-area cancer center

Fatty acids promote immune suppression and therapy resistance in triple negative breast cancer, Baylor Medicine study finds

Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State

Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology

Renew today!

Subscriber content

Threats to the NCI COE agenda impede our ability to meet the needs of our cancer center catchment area communities

YOU MAY BE INTERESTED IN

Rathmell: We must put the individual at the center of our approach to ending cancer

In an oral history now taken down by FDA, Andrew von Eschenbach recounts his stint as the head of both FDA and NCI—simultaneously

MD Anderson breaks ground on new Houston-area cancer center

Fatty acids promote immune suppression and therapy resistance in triple negative breast cancer, Baylor Medicine study finds

Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State

Kennedy announces massive cuts, centralization at HHS—NCI and FDA hitAlso this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology

Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology